Shujay Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 01-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 01-11-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.00 Cr
as on 01-11-2024
- Revenue %
(FY 2023)
- Net Worth
- Total Assets 64.40%
(FY 2023)
About Shujay Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹16.00 Cr.
Swapnil Nerkar, Pravinkumar Patel, and Vipulbhai Patel serve as directors at the Company.
- CIN/LLPIN
U24304GJ2020PTC117650
- Company No.
117650
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Shujay Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swapnil Nerkar  | Director | 24-Oct-2020 | Current |
| Pravinkumar Patel | Director | 24-Oct-2020 | Current |
| Vipulbhai Patel | Director | 24-Oct-2020 | Current |
Financial Performance of Shujay Laboratories.
Shujay Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shujay Laboratories?
Unlock access to Shujay Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shubham Specialty Products (India) Private LimitedActive 13 years 9 monthsSwapnil Nerkar is a mutual person
- Shubham Laboratories (India) Private LimitedActive 7 years 6 months
Swapnil Nerkar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Jun 2022 | ₹16.00 Cr | Open |
How Many Employees Work at Shujay Laboratories?
Shujay Laboratories has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shujay Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shujay Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
